LASIK Should Carry Warnings of Possible Complications, FDA Says
New guidance says complications can include dry eyes, double vision, difficulty with night driving, chronic eye pain
Ophthalmic Disorders
Bevacizumab, Aflibercept Compared for Neovascular AMD
At the end of one year, likelihood of being weaned off treatment was higher for eyes treated with aflibercept versus bevacizumab
Lipid-Lowering, Antidiabetic Drugs Tied to Prevalence of AMD
Use of lipid-lowering drugs, antidiabetic drugs associated with lower prevalence of any age-related macular degeneration
October 2022 Recap: Drug Pipeline Updates
The table provided is a review of notable updates that occurred in October 2022 for investigational products in development.
FDA to Review Novel Cyclosporine Ophthalmic Solution for Dry Eye Disease
CyclASol is an investigational topical treatment of cyclosporine that contains no oils or surfactants and is preservative-free.
CDC Report Warns of Serious Ocular Complications With Monkeypox
Prompt initiation of systemic antiviral therapy in addition to topical trifluridine should be considered in patients with ocular manifestations of monkeypox.
Aflibercept Granted Priority Review for Retinopathy of Prematurity
The sBLA is supported by data from the phase 3 FIREFLEYE and BUTTERFLEYE trials that evaluated the efficacy and safety aflibercept in infants with ROP.
Diabetic Macular Edema Treatments
Ophthalmic agents for the treatment of diabetic macular edema (DME).
Neovascular Age-Related Macular Degeneration Treatments
Ophthalmic agents for the treatment of neovascular (wet) age-related macular degeneration (AMD).
